Skip to main content
. 2021 Feb 6;22(4):1650. doi: 10.3390/ijms22041650

Figure 4.

Figure 4

Carb-LL37 proliferating SLE T-cells correlate with SLEDAI and with anti-native LL37 autoantibodies. (a) Proliferation to carb-LL37 expressed and SI plotted against SLEDAI or (b) anti-native LL37 antibody reactivity (anti-LL37 bas). (c,d) Proliferation to cit-LL37 (left panel) or to native LL37 (right panel), expressed and SI, plotted against SLEDAI (c) or against anti-native LL37 antibody reactivity (d). (e,f) CXCR5 expression (as fold-increase with respect to untreated T-cells), in SLE T-cells, in response to carb-LL37 (e) or to either cit-LL37 or native LL37 (f), plotted against the anti-LL37 antibody reactivity (OD). In all panels Spearman’s r, significance p, sample size N, are indicated.